Nicholas J. Hornstein

Nicholas J. Hornstein

Hematology | Oncology
210 East 64th Street
4th Floor
New York, NY 10065

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Age-stratified mutation patterns in early-onset colorectal cancer reveal distinct molecular features and therapeutic implications.

Age-stratified mutation patterns in early-onset colorectal cancer reveal distinct molecular features and therapeutic implications.

Journal: ESMO gastrointestinal oncology
Published: September 03, 2026

Bridging the Gap: Clinical Integration of Thrombopoietin Receptor Agonists in GI Cancer-Associated Chemotherapy-Induced Thrombocytopenia.

Bridging the Gap: Clinical Integration of Thrombopoietin Receptor Agonists in GI Cancer-Associated Chemotherapy-Induced Thrombocytopenia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 01, 2026

Patient-reported outcomes and targeted therapeutic escalation in NRG Oncology/RTOG 1010: When intensification fails to translate to improved outcomes.

Patient-reported outcomes and targeted therapeutic escalation in NRG Oncology/RTOG 1010: When intensification fails to translate to improved outcomes.

Journal: Cancer
Published: August 12, 2026

Metastatic Large Cell Calcifying Sertoli Cell Tumor: A Case Report, Diagnostic Pitfalls, and Literature Review.

Metastatic Large Cell Calcifying Sertoli Cell Tumor: A Case Report, Diagnostic Pitfalls, and Literature Review.

Journal: International journal of surgical pathology
Published: July 10, 2026

RAF/MEK Clamp Inhibition with Avutometinib and Cetuximab in RAF1 S257L-Mutated, Anti-EGFR-Refractory Metastatic Colorectal Cancer in Gaucher's disease.

RAF/MEK Clamp Inhibition with Avutometinib and Cetuximab in RAF1 S257L-Mutated, Anti-EGFR-Refractory Metastatic Colorectal Cancer in Gaucher's disease.

Journal: The oncologist
Published: July 08, 2026

Has Colorectal Cancer (c-)Met Its Match With Telisotuzumab Adizutecan?

Has Colorectal Cancer (c-)Met Its Match With Telisotuzumab Adizutecan?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 27, 2026

KRAS inhibition is an effective therapy for appendiceal adenocarcinoma.

KRAS inhibition is an effective therapy for appendiceal adenocarcinoma.

Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026

Characterizing symptom patterns in early-onset colorectal cancer: insights from a national inpatient analysis.

Characterizing symptom patterns in early-onset colorectal cancer: insights from a national inpatient analysis.

Journal: Cancer treatment and research communications
Published: March 23, 2026

KRAS inhibition is an effective therapy for appendiceal adenocarcinoma.

KRAS inhibition is an effective therapy for appendiceal adenocarcinoma.

Journal: Journal of hematology & oncology
Published: February 27, 2026

Viral vs. Non-Viral Combined Hepatocellular-Cholangiocarcinoma: Distinct Genomic Landscapes and Survival Outcomes.

Viral vs. Non-Viral Combined Hepatocellular-Cholangiocarcinoma: Distinct Genomic Landscapes and Survival Outcomes.

Journal: Journal of gastrointestinal cancer
Published: February 16, 2026

Premature discontinuation of clinical trials in biliary tract cancers: Predictors and implications.

Premature discontinuation of clinical trials in biliary tract cancers: Predictors and implications.

Journal: Journal of cancer policy
Published: January 11, 2026

Germline genetic testing among patients with pancreatic adenocarcinoma: A Pancreatic Cancer Action Network patient survey.

Germline genetic testing among patients with pancreatic adenocarcinoma: A Pancreatic Cancer Action Network patient survey.

Journal: Cancer
Published: December 15, 2025
Showing 1-12 of 35

Last Updated: 09/26/2026